MilbeVet 4 mg/10 mg Film-coated Tablets for Small Cats and Kittens

The possibility that other animals in the same household can be a source of re-
infection should be considered, and these should be treated as necessary with
an appropriate veterinary medicinal product.
It is recommended to treat all the animals living in the same household
concomitantly.
When infection with the cestode D. caninum has been confirmed, concomitant
treatment against intermediate hosts, such as fleas and lice, should be
discussed with a veterinarian to prevent re-infection.
Unnecessary use of antiparasitics or use deviating from the instructions given in
the SPC may increase the resistance selection pressure and lead to reduced
efficacy. The decision to use the veterinary medicinal product should be based
on confirmation of the parasitic species and burden, or of the risk of infection
based on its epidemiological features, for each individual animal.
In the absence of risk of co-infection with nematodes or cestodes, a narrow
spectrum veterinary medicinal product should be used when available.
The use of this veterinary medicinal product should take into account local
information about susceptibility of the target parasites, where available.

Special precautions for use in animals
Ensure cats and kittens weighing between 0.5 kg and ≤2 kg receive the
appropriate tablet strength (4 mg MBO/10 mg praziquantel) and the appropriate
dose.
See also section 4.9.
No studies have been performed with severely debilitated cats or individuals
with seriously compromised kidney or liver function. The veterinary medicinal
product is not recommended for such animals or only according to a benefit/risk
assessment by the responsible veterinarian.
Special precautions to be taken by the person administering the veterinary
medicinal product to animals
Wash hands after use.
In case of accidental ingestion of the tablets, particularly by a child, seek
medical advice immediately and show the package leaflet or the label to the
physician.

Revised: September 2025
AN: 01475/2025Page 3 of 7
Special precautions for the protection of the environment
See section 6.6.
Other precautions
Echinococcosis represents a hazard for humans. As Echinococcosis is a
notifiable disease to the World Organisation for Animal Health (WOAH), specific
guidelines on the treatment and follow up and on the safeguard of persons need
to be obtained from the relevant competent authority (e.g. experts or institutes
of parasitology).